Terms: = Breast cancer AND SND1, Q7KZF4, TDRD11, p100, ENSG00000197157, 27044 AND Treatment
9 results:
1. Structure-Based Design, Optimization, and Evaluation of Potent Stabilized Peptide Inhibitors Disrupting MTDH and snd1 Interaction.
Chen H; Zhan M; Liu J; Liu Z; Shen M; Yang F; Kang Y; Yin F; Li Z
J Med Chem; 2022 Sep; 65(18):12188-12199. PubMed ID: 36044768
[TBL] [Abstract] [Full Text] [Related]
2. Pharmacological disruption of the MTDH-snd1 complex enhances tumor antigen presentation and synergizes with anti-PD-1 therapy in metastatic breast cancer.
Shen M; Smith HA; Wei Y; Jiang YZ; Zhao S; Wang N; Rowicki M; Tang Y; Hang X; Wu S; Wan L; Shao ZM; Kang Y
Nat Cancer; 2022 Jan; 3(1):60-74. PubMed ID: 35121988
[TBL] [Abstract] [Full Text] [Related]
3. Role of metadherin in estrogen-regulated gene expression.
Li Y; Gonzalez Bosquet J; Yang S; Thiel KW; Zhang Y; Liu H; Leslie KK; Meng X
Int J Mol Med; 2017 Aug; 40(2):303-310. PubMed ID: 28627585
[TBL] [Abstract] [Full Text] [Related]
4. Inhibitory effect of miR-184 on the potential of proliferation and invasion in human glioma and breast cancer cells in vitro.
Feng R; Dong L
Int J Clin Exp Pathol; 2015; 8(8):9376-82. PubMed ID: 26464691
[TBL] [Abstract] [Full Text] [Related]
5. Electroretinographic and optical coherence tomography findings in breast cancer patients using aromatase inhibitors.
Moschos MM; Chatziralli IP; Sergentanis T; Zagouri F; Chrysikos D; Ladas I; Zografos G
Cutan Ocul Toxicol; 2016 Mar; 35(1):13-20. PubMed ID: 25597370
[TBL] [Abstract] [Full Text] [Related]
6. Noncanonical NF-κB activation mediates STAT3-stimulated IDO upregulation in myeloid-derived suppressor cells in breast cancer.
Yu J; Wang Y; Yan F; Zhang P; Li H; Zhao H; Yan C; Yan F; Ren X
J Immunol; 2014 Sep; 193(5):2574-86. PubMed ID: 25063873
[TBL] [Abstract] [Full Text] [Related]
7. A selective small-molecule nuclear factor-kappaB inhibitor from a high-throughput cell-based assay for "activator protein-1 hits".
Kang MI; Henrich CJ; Bokesch HR; Gustafson KR; McMahon JB; Baker AR; Young MR; Colburn NH
Mol Cancer Ther; 2009 Mar; 8(3):571-81. PubMed ID: 19258426
[TBL] [Abstract] [Full Text] [Related]
8. [NF-kappa B and cancers].
Bours V
Bull Mem Acad R Med Belg; 1999; 154(6 Pt 2):335-45. PubMed ID: 10992882
[TBL] [Abstract] [Full Text] [Related]
9. Latent transformed growth-inhibiting factor in human malignant effusions.
Podolsky DK; Pleskow DK; Jafari H
Cancer Res; 1988 Jan; 48(2):418-24. PubMed ID: 3257164
[TBL] [Abstract] [Full Text] [Related]
